Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - 2023 - The FEBS Journal - Wiley Online Library
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
PE Anti-Kappa light chain antibody [TB28-2] (ab131602) | Abcam
JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
Immunoglobulin Kappa Chain - an overview | ScienceDirect Topics
Guide to Antibody structure and isotypes | Abcam
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
Providence Health Care Test Catalog
British Journal of Haematology | Wiley Online Library
Nephron Power: February 2016
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
APC Mouse anti-Human Ig, κ Light Chain
Living With - HealthTree for Multiple Myeloma
Frontiers | High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
SARS-CoV-2 infection associated with monoclonal gammopathy. A case report based on the study of minimally invasive ultrasound-guided autopsy | Revista Española de Patología